ACAD
37.62
-0.29
-0.76%
AEMD
7.065
-0.085
-1.189%
APRI
1.38
+0.15
+12.20%
ARNA
2.66
+0.01
+0.38%
ATEC
0.572
+0.002
+0.3333%
CNAT
3.95
+0.27
+7.34%
CRXM
0.311
-0.079
-20.256%
CYTX
0.304
+0.004
+1.4367%
DXCM
95.18
+1.44
+1.54%
GNMK
9.705
+0.275
+2.916%
HALO
17.96
-0.08
-0.44%
ILMN
201.46
-0.48
-0.24%
INNV
0.145
0.00
0.00%
INO
7.47
+0.49
+7.02%
ISCO
4
+0.35
+9.59%
ISIS
50.83
-0.73
-1.42%
LGND
94.42
+0.17
+0.18%
LPTN
0.215
+0.005
+2.4750%
MBVX
1.73
+0.04
+2.37%
MEIP
1.72
+0.03
+1.7692%
MNOV
3.01
+0.04
+1.35%
MRTX
25.72
+0.23
+0.90%
MSTX
0.464
+0.012
+2.632%
NBIX
46.22
-0.04
-0.09%
NUVA
52.935
+0.185
+0.351%
ONCS
5.088
-0.087
-1.681%
ONVO
2.495
-0.005
-0.200%
OREX
2.83
+0.07
+2.54%
OTIC
22.75
-0.63
-2.69%
QDEL
20.28
-0.42
-2.03%
RCPT
231.96
0.00
0.00%
RGLS
7.9
+0.42
+5.61%
RMD
52.06
+0.41
+0.79%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.871
+0.011
+1.2558%
SRNE
13.47
+0.15
+1.13%
TROV
6.306
+0.526
+9.100%
VICL
0.57
+0.01
+1.75%
VOLC
18
0.00
0.00%
ZGNX
17.71
+0.65
+3.81%
ACAD
37.62
-0.29
-0.76%
AEMD
7.065
-0.085
-1.189%
APRI
1.38
+0.15
+12.20%
ARNA
2.66
+0.01
+0.38%
ATEC
0.572
+0.002
+0.3333%
CNAT
3.95
+0.27
+7.34%
CRXM
0.311
-0.079
-20.256%
CYTX
0.304
+0.004
+1.4367%
DXCM
95.18
+1.44
+1.54%
GNMK
9.705
+0.275
+2.916%
HALO
17.96
-0.08
-0.44%
ILMN
201.46
-0.48
-0.24%
INNV
0.145
0.00
0.00%
INO
7.47
+0.49
+7.02%
ISCO
4
+0.35
+9.59%
ISIS
50.83
-0.73
-1.42%
LGND
94.42
+0.17
+0.18%
LPTN
0.215
+0.005
+2.4750%
MBVX
1.73
+0.04
+2.37%
MEIP
1.72
+0.03
+1.7692%
MNOV
3.01
+0.04
+1.35%
MRTX
25.72
+0.23
+0.90%
MSTX
0.464
+0.012
+2.632%
NBIX
46.22
-0.04
-0.09%
NUVA
52.935
+0.185
+0.351%
ONCS
5.088
-0.087
-1.681%
ONVO
2.495
-0.005
-0.200%
OREX
2.83
+0.07
+2.54%
OTIC
22.75
-0.63
-2.69%
QDEL
20.28
-0.42
-2.03%
RCPT
231.96
0.00
0.00%
RGLS
7.9
+0.42
+5.61%
RMD
52.06
+0.41
+0.79%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.871
+0.011
+1.2558%
SRNE
13.47
+0.15
+1.13%
TROV
6.306
+0.526
+9.100%
VICL
0.57
+0.01
+1.75%
VOLC
18
0.00
0.00%
ZGNX
17.71
+0.65
+3.81%
Home » Events

SDBN October 26th Event Featuring Trius Therapeutics

Submitted by on October 19, 2010 – 2:57 pm

Dr. John Finn, Trius Therapeutics’ Chief Scientific Officer, will present a talk titled “Innovative Antibacterial Drugs by Design; The Trius Therapeutics Story.”

Date/Time Start:: Oct. 26 5:30 p.m.

Date/Time End:: Oct. 26th 9:00 p.m.

Cost to Attend: ( Academic)

Web Address:: http://sdbn.org/october

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


nine − = 2